DNA Q1 2025 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$48M+27.3% YoY

Gross Profit

$36M75.1% margin

Operating Income

-$89M-184.1% margin

Net Income

-$91M-188.2% margin

EPS (Diluted)

$-1.68

QoQ Revenue Growth

+10.2%

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$59M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$646M

Stockholders' Equity

$647M

Cash & Equivalents

$312M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$38M	+27.3%
Gross Profit	$36M	$29M	+26.2%
Operating Income	-$89M	-$178M	+50.0%
Net Income	-$91M	-$166M	+45.2%

Revenue Segments

Service

$10M100%